NBIX Director Morrow sells 15,000 shares ($2.2M) at $143.37; -68.0% of holdings with 100% well-timed sell pattern
Director George J Morrow sold 15,000 shares (15.0K shares) of NEUROCRINE BIOSCIENCES INC at $143.37 on 2025-11-25, reducing his stake from 22,068 shares (22.1K shares) to 7,068 shares (7.1K shares)—a reduction of 68.0% of pre-transaction holdings. His cross-ticker track record shows 2 prior sells with a 90-day well-timed rate of 100.00%, and at NBIX specifically, both of his 2 prior trades were well-timed at the 90-day mark, indicating a consistent pattern of selling ahead of subsequent declines. The current stock price of $151.58 stands at -2.1% from the 52-week high and has gained 9.1% over the past 90 days, placing this sale near recent cyclical peaks. With NBIX trading at a P/E of 35.33 and posting strong fundamentals (revenue $794.9M, net income $209.5M, annual revenue growth +24.8%), the timing of this large directional reduction by a director merits investor attention given the insider's demonstrated pattern of sell execution relative to subsequent price action.